I'm referring to the announcement last August.
4 patients treated in a trial that ran for 2.5 years. Management kept being extremely coy about details of trial progress.
I suppose it was really 2 years, with the clinical trial website stating that the trial had ceased due to poor patient enrollment in Dec 2022. It just took management another 8 months to update shareholders.
That's definitely what I'd call a trial failure. Management, governance and communication failures also.
I'm referring to the announcement last August.4 patients...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 45.5¢ | $215.4K | 467.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 175506 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 104491 | 2 |
View Market Depth
| Last trade - 15.59pm 11/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |